Postprandial renal haemodynamic effect of lixisenatide vs once‐daily insulin‐glulisine in patients with type 2 diabetes on insulin‐glargine: An 8‐week, randomised, open‐label trial-Reference-Cited by-同舟云学术

Postprandial renal haemodynamic effect of lixisenatide vs once‐daily insulin‐glulisine in patients with type 2 diabetes on insulin‐glargine: An 8‐week, randomised, open‐label trial

Published:2017-07-25 Issue:12 Volume:19 Page:1669-1680
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Tonneijck Lennart¹^ORCID,Muskiet Marcel H. A.¹,Smits Mark M.¹,Hoekstra Trynke²³,Kramer Mark H. H.¹,Danser A. H. Jan⁴,Diamant Michaela¹,Joles Jaap A.⁵,van Raalte Daniël H.¹^ORCID

Affiliation:

1. Department of Internal Medicine, Diabetes CenterVU University Medical Center Amsterdam The Netherlands

2. Department of Health Sciences and the EMGO Institute for Health and Care ResearchVU University Amsterdam Amsterdam The Netherlands

3. Department of Epidemiology and BiostatisticsVU University Medical Center Amsterdam The Netherlands

4. Division of Pharmacology and Vascular Medicine, Department of Internal MedicineErasmus University Medical Center Rotterdam The Netherlands

5. Department of Nephrology and HypertensionUniversity Medical Center Utrecht The Netherlands

Funder

Sanofi-Aventis

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12985

Reference41 articles.

1. Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas

2. The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?

3. Pleiotropic effects of type 2 diabetes management strategies on renal risk factors

4. Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment

5. Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and urea

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The influence of insulin and incretin-based therapies on renal tubular transport;Journal of Nephrology;2024-08-21

2. Incretin-based therapy: a new horizon in diabetes management;Journal of Diabetes & Metabolic Disorders;2024-08-17

3. Incretin and glucagon receptor polypharmacology in chronic kidney disease;American Journal of Physiology-Endocrinology and Metabolism;2024-06-01

4. The effect of subcutaneous Lixisenatide on weight loss in patients with type 2 Diabetes Mellitus: Systematic review and Meta-Analysis of randomized controlled trials;Diabetes Research and Clinical Practice;2024-04

5. The effects of semaglutide, empagliflozin and their combination on the kidney sodium signal from magnetic resonance imaging: A prespecified, secondary analysis from a randomized, clinical trial;Journal of Diabetes and its Complications;2024-02